Fátt ógurlegra en að hakkarar geti stjórnað hjartslætti fólks
Sent: Sun 03. Sep 2017 20:37
Tölvu og tækniáhuga samfélagið.
https://spjall.vaktin.is/
rapport skrifaði:https://thehackernews.com/2017/08/pacemakers-hacking.html
Tuesday, September 5th, 2018, Baltimore MD, Insilico Medicine today announced that its founder and CEO, Alex Zhavoronkov will present the company's latest research on the application of generative adversarial networks (GANs) and Reinforcement Learning (RL) for validation, quality control, reconstruction and management of healthcare data on Blockchain platforms at the AI and Blockchain for Healthcare Innovation Forum in Basel, Switzerland, September 12-13, 2017.
The revolution in artificial intelligence (AI) commenced in 2014, which was signalled by a technique called deep learning significantly and conclusively outperforming humans in image recognition, and subsequently voice recognition and autonomous driving. The application of AI is now also transforming drug discovery. Another area, which is also advancing rapidly is Blockchain technology, and while it may not be immediately obvious, these two technologies are converging and enabling each other. To explore the potential of bridging AI and Blockchain in Healthcare, Insilico Medicine, a Baltimore-based next-generation artificial intelligence company is co-organizing the "Artificial Intelligence and Blockchain for Healthcare" innovation forum in Basel, Switzerland, September 12-13, 2017.
"Blockchain and AI technologies are extremely complimentary and are enabling new, previously unthinkable applications in healthcare. Blockchain allows us to learn on large multi-modal data sets in a secure and private manner and deep learning technologies enable rapid validation, quality control, uniqueness, valuation and much more. Through our partnership with BitFury we are able to take advantage of the cutting edge Blockchain expertise, unique Exonum platform features and application-specific semiconductors. I am very happy to present our research results in Basel at our inaugural AI and Blockchain for Healthcare innovation forum at the EMBO/Basel Life", said Alex Zhavoronkov, PhD, CEO of Insilico Medicine.